Biotech · South San Francisco, CA · Founded 2023 · Privately Held (backing)
Developer of life-changing medicines designed through the transformative power of artificial intelligence. Xaira Therapeutics is based in South San Francisco, CA and was founded in 2023. It was valued at $3.5 billion at its early-stage round in Aug 2025, the last priced event on record. It has raised $1.3 billion across 1 recorded round; the latest was a $1 billion Series A in Apr 2024.
PMV mark · valuation
$3.5B
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$1.3B
Last round
Series A
Apr 2024
Cap table — not yet on record
Xaira Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Xaira Therapeutics with a free account
·The complete investor list: 20 names
·Watch Xaira Therapeutics: the Monday email on marks, rounds and moves
Where does Xaira Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Xaira Therapeutics's 1 recorded funding rounds.
